Erste Asset Management’s Sana Biotechnology SANA Stock Holding History

Erste Asset Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,000	Closed	-$112K	–	807
2025 Q2	$112K	Hold	40,000	–	–	﹤0.01%	818
2025 Q1	$68.4K	Hold	40,000	–	–	﹤0.01%	503
2024 Q4	$64.4K	Hold	40,000	–	–	﹤0.01%	512
2024 Q3	$171K	Hold	40,000	–	–	﹤0.01%	486
2024 Q2	$216K	Hold	40,000	–	–	﹤0.01%	476
2024 Q1	$400K	Hold	40,000	–	–	0.01%	444
2023 Q4	$174K	Hold	40,000	–	–	﹤0.01%	485
2023 Q3	$160K	Hold	40,000	–	–	﹤0.01%	488
2023 Q2	$236K	Hold	40,000	–	–	﹤0.01%	478
2023 Q1	$124K	Hold	40,000	–	–	﹤0.01%	523
2022 Q4	$152K	Hold	40,000	–	–	﹤0.01%	522
2022 Q3	$223K	Hold	40,000	–	–	0.01%	490
2022 Q2	$250K	Hold	40,000	–	–	0.01%	493
2022 Q1	$326K	Buy	+40,000	New	+$323K	0.01%	474

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Erste Asset Management's SANA Position: Q3 2025 in Review

Erste Asset Management sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 40,000 shares — an estimated $112K sold.

Erste Asset Management first reported a position in SANA in Q1 2022 and held it in 14 quarters. The position peaked at $400K in Q1 2024. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

Erste Asset Management reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
Erste Asset Management sold 40,000 Sana Biotechnology shares in Q3 2025, an estimated $112K.
Erste Asset Management first reported a position in Sana Biotechnology in Q1 2022 and held it in 14 quarters.
Erste Asset Management's Sana Biotechnology position peaked at $400K in Q1 2024.
178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Erste Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.